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oseph priestley, one of the three scientists credited with the
 
discovery of oxygen, described the death of mice that were deprived of oxygen.
However, he was also well aware of the toxicity of too much oxygen, stating, “For as
a candle burns much faster in dephlogisticated [oxygen-enriched] than in common
air, so we might live out too fast, and the animal powers be too soon exhausted in this
pure kind of air. A moralist, at least, may say, that the air which nature has provided for
us is as good as we deserve.”
 
1
 
In this review we examine the remarkable mechanisms by which different organs
detect and respond to acute changes in oxygen tension. Specialized tissues that sense
the local oxygen tension include glomus cells of the carotid body, neuroepithelial bod-
ies in the lungs, chromaffin cells of the fetal adrenal medulla, and smooth-muscle cells
of the resistance pulmonary arteries, fetoplacental arteries, systemic arteries, and the
ductus arteriosus. Together, they constitute a specialized homeostatic oxygen-sensing
system. Although all tissues are sensitive to severe hypoxia, these specialized tissues
respond rapidly to moderate changes in oxygen tension within the physiologic range
(roughly 40 to 100 mm Hg in an adult and 20 to 40 mm Hg in a fetus) (Fig. 1).
In fetal life, the pulmonary vascular bed has a high resistance to blood flow. Conse-
quently, oxygenated blood returning from the placenta is diverted from the unventilated
lungs and across the foramen ovale and ductus arteriosus. At birth, when air breathing
begins, the lungs expand and oxygen levels rise. With reversal of fetal hypoxic pulmo-
nary vasoconstriction, the pulmonary vessels dilate and the ductus arteriosus constricts,
thereby establishing the transition from the fetal to the neonatal circulation.
After birth, hypoxic pulmonary vasoconstriction remains important, because it re-
duces perfusion of poorly ventilated areas of lung, and in so doing it decreases the
shunting of desaturated, mixed venous blood to the systemic circulation. Inhibition of
hypoxic pulmonary vasoconstriction reduces the systemic arterial oxygen tension, par-
ticularly in small-airway disease.
 
2
 
 Moreover, as was first demonstrated in humans in
1947,
 
3
 
 the intensity of hypoxic pulmonary vasoconstriction depends on the severity
and duration of alveolar hypoxia.
 
4,5
 
The endothelium produces vasodilators, such as nitric oxide and prostacyclin, and
vasoconstrictors, such as endothelin and thromboxane A
 
2
 
; these molecules from endo-
thelial cells modulate hypoxic pulmonary vasoconstriction, but the ability of small pul-
monary vessels to contract in response to hypoxia resides in their smooth-muscle
cells.
 
6
 
 Three sites in these cells are involved in the mechanism of hypoxic pulmonary
vasoconstriction: the membrane, the sarcoplasmic reticulum, and the contractile ap-
paratus.
j
hypoxic pulmonary vasoconstriction
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the smooth-muscle-cell membrane
 
At the smooth-muscle-cell membrane in the pul-
monary artery, hypoxic inhibition of the outward
potassium current causes depolarization of the
membrane and entry of calcium through L-type
voltage-gated calcium channels (see the glossary for
definitions of terms).
 
7,8
 
 The membrane potential,
and therefore control of voltage-gated calcium
 
Figure 1. Homeostatic Oxygen-Sensing System.
 
Specialized tissues that sense the local oxygen level are shown. The carotid body at the carotid-artery bifurcation increases action-potential 
frequency in the carotid-sinus nerve in response to hypoxia, thus stimulating respiration. The small resistance pulmonary and fetoplacental 
arteries demonstrate hypoxic vasoconstriction, optimizing oxygen transfer in the lung and placenta. The ductus arteriosus, by contrast, con-
tracts when oxygen levels rise, redirecting blood through the newly expanded lungs of the newborn. The neuroepithelial bodies in the lungs 
and adrenomedullary cells in the fetus also sense oxygen.
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channels in the membrane of the smooth-muscle
cell, is largely determined by the movement of
potassium across the membrane from a high con-
centration inside the cell (145 mM) to a low con-
centration outside the cell (5 mM). At the resting
membrane potential (about –60 mV) these calcium
channels are mostly closed. Figure 2 shows the se-
quence of inhibition of potassium current, mem-
brane depolarization, and entry of calcium ions
elicited by hypoxia.
 
7,8
 
 Hypoxia inhibits potassium
current and depolarizes smooth-muscle cells in the
pulmonary arteries, but it does not have these ef-
fects in smooth-muscle cells from vascular beds
that dilate in response to hypoxia (e.g., those of the
kidney or mesentery). Inhibition of potassium cur-
rent is proportional to the severity of hypoxia
 
9
 
 and
is more prominent in small resistance pulmonary
arteries (diameter, <500 µm) than in large extra-
parenchymal pulmonary arteries.
 
10
 
A variety of potassium channels in smooth-
muscle cells of the pulmonary arteries are sensitive
to acute changes in oxygen.
 
11
 
 In the fetus, the cal-
 
Glossary
Membrane depolarization:
 
 Potassium-channel inhibition, whether by a chemical or by oxygen tension, leads to accumulation of positively 
charged potassium ions (K
 
+
 
) within the cell, and this positive shift in membrane potential (i.e., depolarization from –60 mV) activates 
voltage-gated, L-type calcium channels, promoting calcium influx.
 
Membrane potential:
 
 The voltage difference across the cell plasma membrane that results from a charge separation of ions. There is a bal-
ance between negatively charged macromolecules trapped within the cell and the asymmetric distribution of ions. More potassium ions 
(K
 
+
 
) and anionic proteins are within the cell and more Cl
 
–
 
 and Na
 
+
 
 ions are outside. The ions can cross the membrane only through se-
lective pores, called ion channels, or by means of pumps and transporters. Ion-channel opening, especially that of K
 
+
 
 channels, largely 
controls membrane potential. At a certain point (the equilibrium potential) the tendency of an ion to exit or enter the cell based on its 
concentration gradient is exactly balanced by the electrostatic (charge) forces.
 
Mitochondrial electron transport chain:
 
 A cascade of proteins and iron-sulfur complexes within the inner mitochondrial membrane that 
shuttle electrons derived from NADH oxidation down the redox potential gradient to molecular oxygen. In addition to driving ATP syn-
thesis, the electron transport chain creates a leak of reactive oxygen species, owing to uncoupled electron transfer.
 
Potassium channels:
 
 Tetrameric proteins in the cell membrane. They have a highly conserved pore region with a potassium-recognition 
sequence that determines ion specificity. There is great diversity in the N and C terminals of potassium channels that regulate channel 
expression and gating. The major classes of potassium channels include voltage-gated, inward rectifier, and two-pore. 
 
b
 
 subunits asso-
ciate with many potassium channels and alter their expression and kinetics.
 
Reactive oxygen species:
 
 Substances, created in small amounts in the course of oxygen metabolism, that include stable diffusible substanc-
es such as hydrogen peroxide and unstable toxic radicals (which have an unpaired electron), such as superoxide and hydroxyl radicals. 
Originally recognized as toxic products of radiation, the reactive oxygen species are now recognized as redox-generated messengers that 
change the function or conformation of target molecules, such as sulfhydryl-rich potassium channels and also control enzymes, such as 
deacetylases that control gene transcription and apoptosis. Reactive oxygen species are produced from the mitochondrial electron trans-
port chain (complexes I and III) and oxidases, such as NADPH oxidase.
 
Redox:
 
 A contraction for “reduction–oxidation.” Redox reactions are most simply defined as the transfer of electrons between pairs of chem-
ical species so that the electron donor is “oxidized” and the recipient is “reduced.”
 
RhoA and Rho kinase:
 
 Rho kinase is a serine–threonine kinase that is activated by the GTP-binding protein RhoA. Rho kinase phosphory-
lates the regulatory subunit of smooth-muscle myosin phosphatase and inhibits phosphatase activity, thereby mediating calcium sensiti-
zation of the contractile apparatus. Sensitization causes sustained contraction of vascular smooth muscle in response to hypoxia and 
vasoconstrictor agonists, even after calcium concentrations decline. Inhibition of Rho kinase relaxes most arteries and counteracts 
vasoconstriction.
 
Sarcoplasmic reticulum:
 
 A membranous intracellular organelle that participates in calcium homeostasis by buffering (accumulating) intra-
cellular calcium. During relaxation calcium is sequestered, and during contraction it is released. Calcium handling is controlled by sarco-
plasmic reticulum Ca
 
2
 
+
 
-ATPase (SERCA) and two types of Ca
 
2
 
+
 
 channels, the ryanodine receptor and the inositol 1,4,5-triphosphate 
receptor.
 
Store-operated channels:
 
 Depletion of intracellular calcium stores results in capacitative calcium influx via store-operated channels. On a 
molecular level, store-operated channels appear to be encoded by transient receptor potential (TRP) genes. The store-operated channels 
are involved in regulation of vascular tone and cell proliferation.
 
Two-pore acid-sensitive potassium channels (TASK channels):
 
 A family of potassium channels that, unlike most others, has two pore do-
mains. They are not gated by voltage but conduct a basal leak current at negative membrane potentials that contributes to resting mem-
brane potential. TASK channels are inhibited by acidic pH and activated by certain anesthetic agents, such as halothane.
 
Voltage-gated (L-type) calcium channels:
 
 Large, long-lasting calcium channels that are voltage activated. When open, they permit influx of 
calcium into excitable cells down the calcium concentration gradient (2 mM extracellular vs. 100 nM intracellular). L-type channels are 
critical to the control of vascular tone but are also involved in neurotransmitter release, gene expression, and cell proliferation. They are 
blocked by dihydropyridines (e.g., nifedipine), phenylalkylamines, and benzothiazepines.
 
Voltage-gated potassium (Kv) channels:
 
 Kv channels have an arginine-and-lysine–rich voltage sensor in their fourth transmembrane domain 
region. This sensor changes in conformation with membrane depolarization, thus opening the channel. There are several families of Kv 
channels (Kv1 through Kv9), each with isoforms (e.g., Kv1.1 through Kv1.6).
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cium-sensitive potassium channel (K
 
Ca
 
) is the pre-
dominant oxygen-sensitive channel.
 
12
 
 After birth,
a shift to several voltage-gated potassium channels
(Kv; this nomenclature refers to K channel, voltage-
dependent) occurs.
 
11
 
 For instance, hypoxia inhibits
Kv1.5, which has been cloned from human pulmo-
nary arteries,
 
13
 
 and hypoxic pulmonary vasocon-
striction is diminished in mice that lack this chan-
nel.
 
11
 
 Acute hypoxic pulmonary vasoconstriction is
blunted in rats previously exposed to chronic hy-
poxia,
 
14
 
 and chronic hypoxia decreases the oxygen-
sensitive component of potassium current and the
expression of Kv1.5 and Kv2.1 in smooth-muscle
cells of the pulmonary arteries.
 
15-18
 
 These findings,
together with the observation that the diminution
of hypoxic pulmonary vasoconstriction by chron-
ic hypoxia in rats can be restored by aerosol trans-
fection of human Kv1.5,
 
19
 
 have established a role for
 
Figure 2. Opposite Regulation of Potassium Channels by Oxygen in Pulmonary-Artery as Compared with Ductus Smooth-Muscle Cells.
 
In the pulmonary-artery smooth-muscle cell (shown in the upper half of the figure) during normoxia, an outward potassium (K
 
+
 
) current, 
illustrated by the single channel trace that shows steplike opening and closing, keeps the membrane potential at about ¡50 mV or ¡60 mV. 
This hyperpolarization prevents calcium from entering the cell through the voltage-gated L-type calcium channel. Hypoxia inhibits potassium-
channel activity and depolarizes the membrane to about ¡20 mV, permitting calcium entry. In the ductus smooth-muscle cell (lower half of the 
figure), by contrast, the outward potassium current is maintained during hypoxia and is inhibited by normoxia. A rise in oxygen, as at birth, 
then causes membrane depolarization and calcium entry.
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Kv channels, and particularly Kv1.5, in the mech-
anism of hypoxic pulmonary vasoconstriction.
Kv2.1 and Kv3.1b and another potassium channel,
two-pore acid-sensitive potassium channel type 1
(TASK-1), may also be involved.
 
13,20,21
 
 Vasocon-
striction caused by hypoxic inhibition of potassium
current must involve membrane depolarization, but
even after marked depolarization has been induced
in ring segments of pulmonary arteries by the ad-
dition of 80 mM of potassium chloride, hypoxia
causes further contraction.
 
22
 
 This observation in-
dicates that hypoxic pulmonary vasoconstriction
also involves other mechanisms.
 
release of calcium from the sarcoplasmic 
reticulum
 
The L-type calcium-channel blocker nifedipine re-
duces the severity of acute hypoxic pulmonary vaso-
constriction provoked in patients with chronic lung
disease by more than 50 percent.
 
23
 
 Whereas most
of the calcium involved in hypoxic pulmonary va-
soconstriction comes from outside the cell, some
comes from internal stores.
 
9
 
 The observation that
depletion of calcium in the intracellular sarcoplas-
mic reticulum reduces hypoxic pulmonary vasocon-
striction led to the conclusion that hypoxia normal-
ly causes release of calcium from this store.
 
24-26
 
Release then leads to repletion of the sarcoplasmic
reticulum by influx of calcium into the smooth-
muscle cell that occurs through store-operated
calcium channels.
 
27-30
 
 Inhibitors of these channels
block calcium influx into the smooth-muscle cells
of the pulmonary arteries that are stimulated by hy-
poxia
 
27
 
 and prevent hypoxic pulmonary vasocon-
striction.
 
28
 
In summary, the response of the smooth-muscle
cells in the pulmonary arteries to acute hypoxia be-
gins within seconds and involves inhibition of po-
tassium current, membrane depolarization, and
calcium entry through L-type calcium channels; it
also involves calcium release from the sarcoplas-
mic reticulum and calcium repletion through store-
operated channels.
 
r
 
ho
 
a/r
 
ho
 
-kinase augmentation of hypoxic 
pulmonary vasoconstriction
 
Contraction of vascular smooth-muscle cells is ini-
tiated by phosphorylation of myosin light chain,
which is induced by the calcium–calmodulin–
dependent myosin light-chain kinase. Dephosphor-
ylation is mediated by myosin light-chain phos-
phatase. Consequently, vascular tone is modulated
by the balance of activities between the kinase and
the phosphatase. At any given level of cytosolic cal-
cium, the degree of contraction of smooth-muscle
cells caused by the interaction of actin with myosin
can be increased by inhibition of the myosin light-
chain phosphatase.
 
31
 
 In the contractile response to
hypoxia, the dissociation between a sustained level
of cytosolic calcium and gradually increasing con-
traction of small pulmonary arteries is important.
 
32
 
Hypoxia, acting through the small G protein RhoA,
stimulates Rho kinase,
 
33
 
 which inhibits myosin
light-chain phosphatase, thereby increasing phos-
phorylation of the light chain and augmenting
contraction. Consequently, Rho kinase increases
hypoxic pulmonary vasoconstriction,
 
34
 
 and Rho-
kinase inhibitors reduce hypoxic pulmonary vaso-
constriction.
 
35,36
 
The importance of oxygen in initiating closure of
the ductus is underlined by the occurrence of six
times as many cases of patent ductus arteriosus in
babies born at high altitude (approximately 4000 m)
as in those born at sea level.
 
37
 
 Oxygen-induced
membrane depolarization in the ductus arteriosus
occurs because an increase in oxygen tension in-
hibits Kv channels (Fig. 2).
 
38,39
 
 Membrane depo-
larization of smooth-muscle cells in the ductus, as
in those in pulmonary arteries, causes the entry of
calcium, which can be inhibited by L-type calcium-
channel blockers.
 
38,40
 
In a process analogous to the reduction of hy-
poxic pulmonary vasoconstriction in chronic hy-
poxia, rings of ductus arteriosus tissue selectively
fail to constrict in response to oxygen after several
days in culture under normoxic conditions.
 
39
 
 The
messenger RNA (mRNA) for Kv1.5 and Kv2.1 is
diminished in this so-called chronic normoxia
model, and experimental ex vivo gene therapy with
Kv1.5 or Kv2.1 restores much of the contractile
function of the ductus rings.
Hypoxemia in the systemic blood (arterial oxygen
pressure, <60 mm Hg) leads to neurosecretion by
the type 1, or glomus, cells of the carotid body. Ac-
tivation of the carotid body causes the sensation of
breathlessness experienced at high altitudes. Re-
normoxic constriction 
of the ductus arteriosus
hypoxic stimulation
of the carotid body
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lease of acetylcholine and ATP from the carotid body
stimulates sensory-nerve endings in the carotid-
sinus nerve and activates the respiratory center
(Fig. 3). The first demonstration of hypoxic inhibi-
tion of potassium current was made in the glomus
cell.
 
41
 
 Subsequently, Kv, K
 
Ca,
 
 and TASK-like glomus-
cell potassium channels were shown to be oxygen-
sensitive.
 
42-45
 
 As in the pulmonary artery, the rele-
vant oxygen-sensitive channel varies with species
and age. Hypoxic inhibition of these potassium
channels causes membrane depolarization and in-
flux of calcium. The increase in cytosolic calcium
induced by hypoxia does not occur in the absence
of extracellular calcium or without membrane de-
polarization (Fig. 3).
 
46,47
 
 L-type calcium-channel
blockers prevent much of the increase in cytosolic
calcium in glomus cells that is caused by a change
in oxygen tension.
 
46
 
 The increase in cytosolic calci-
um is closely related to the secretion of dopamine
(a neurotransmitter abundant in glomus cells)
(Fig. 3),
 
48
 
 and hypoxia-induced neurosecretion is
prevented by removal of extracellular calcium.
 
49
 
The homeostatic sequence elicited by hypoxia
(potassium-channel inhibition, membrane depo-
larization, calcium entry, and neurosecretion) is
generally accepted. It is less clear which channel ini-
tiates the membrane depolarization, thereby bring-
ing the membrane potential into the range in which
hypoxic inhibition of other potassium channels
contributes to the depolarization. TASK-like chan-
nels are non–voltage-gated channels that are active
at the resting membrane potential (less than –60
mV) of the glomus cell and could fulfill this role.
They are inhibited by hypoxia, which leads to mem-
brane depolarization in acutely isolated glomus
cells. The observation that tetraethylammonium
and iberiotoxin, both inhibitors of K
 
Ca
 
 channels,
cause neurosecretion in cultured slices of the carot-
id body of rats also indicates that K
 
Ca
 
 or Kv chan-
nels, or both, contribute to the setting of resting
membrane potential. This effect of potassium-
channel inhibition has been exploited clinically to
enhance respiration. The respiratory stimulant dox-
apram mimics hypoxia by inhibiting both K
 
Ca
 
 and
Kv currents in glomus cells.
 
50
 
The ion-channel modulation and loss of respon-
siveness to oxygen, elicited in the pulmonary arter-
ies by chronic hypoxia and in the ductus arteriosus
by chronic normoxia, are recapitulated in the carotid
body. There the glomus cells of neonatal rats raised
under hypoxic conditions show reduced potassium
current and hypoxia-induced depolarization.
 
43
 
 The
loss of oxygen-sensing ability caused by chronic
hypoxia may explain the body’s failure to increase
ventilation in response to acute hypoxia in those
living at high altitudes.
 
51
 
 In the pulmonary artery,
the decreased expression of potassium channels
is in part signaled by hypoxia-inducible factor 1
 
a
 
(usually referred to as HIF-1
 
a
 
),
 
52
 
 through its ac-
tions as a regulator of gene transcription.
 
the placenta
 
Fetal arteries in the placenta constrict in response
to hypoxia, diverting fetal blood to cotyledons with
better maternal perfusion.
 
53,54
 
 This response opti-
mizes the transfer of placental oxygen, which, if im-
paired, can cause intrauterine growth retardation.
Hypoxic fetoplacental vasoconstriction also occurs
through the mechanism of potassium-channel in-
hibition.
 
54
 
neuroepithelial bodies
 
Neuroepithelial bodies are clusters of neuroendo-
crine cells in the mucosa of the airway that secrete
amines and peptides in response to hypoxia.
 
55
 
 They
share a common origin with small-cell carcinoma
of the lung and the derived cell line H146.
 
56
 
 Neu-
roepithelial bodies may be involved in hypoxic pul-
monary vasoconstriction and in respiratory con-
trol, especially in the neonate.
 
57
 
 Hypoxia inhibits
potassium current and causes membrane depo-
larization in neuroepithelial bodies and H146
cells,
 
58,59
 
 leading to nifedipine-sensitive calcium
influx
 
57
 
 and secretion of serotonin, which has an
important role in the vascular remodeling that oc-
curs in chronic hypoxic pulmonary hypertension.
 
adrenal chromaffin cells
 
In the fetus and at the time of birth, the adrenal me-
dulla responds to hypoxia by releasing catechola-
mines that improve fetal tolerance of labor. PC12
cells, derived from a pheochromocytoma, manifest
hypoxic inhibition of potassium current, membrane
depolarization, and an increase in cytosolic calci-
um,
 
60
 
 which is largely inhibited by L-type calcium-
channel blockers.
 
other tissues
 
Oxygen-sensitive potassium channels have been
reported in neurons,
 
61
 
 in alveolar epithelial cells,
 
62
 
and in T lymphocytes
 
63
 
; these may be additional
other examples of oxygen 
sensing by potassium channels
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Figure 3. Oxygen Sensing in the Carotid Body.
 
The chief function of the carotid body is to increase respiration in response to hypoxia. The proximal pathway in the type 1 cell of the carotid 
body is similar to that in the pulmonary-artery smooth-muscle cell. Hypoxia inhibits potassium-channel activity, shown in the single channel 
trace, causing membrane depolarization, calcium influx, secretion, and increased action potentials in the carotid-sinus nerve. If the mem-
brane potential (E
 
m
 
) is “clamped” at ¡60 mV, hypoxia no longer leads to an increase in the cytosolic calcium (Ca
 
2+
 
i
 
), indicating that the 
increase in calcium requires membrane depolarization. Cytosolic calcium normally rises sharply as oxygen levels fall below 60 mm Hg. 
Increased calcium stimulates the release of dopamine, a marker for secretion. pA denotes picoamperes.
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tissue locations in which potassium channels medi-
ate rapid responses (seconds to minutes) to altered
oxygen tension. Other ion channels may also be
regulated by changes in oxygen tension in muscle,
neurons, and neurosecretory cells.
 
64
 
effects of changes in the reduction–
oxidation (redox) reaction
 
Whereas the vasoconstrictors endothelin, phenyl-
ephrine, and potassium chloride constrict both the
pulmonary artery and ductus arteriosus, hypoxia
constricts the pulmonary artery but dilates the duc-
tus arteriosus. This effect of hypoxia is shared only
with certain agents that reduce sulfhydryl groups
(redox agents) and inhibitors of complexes I and III
of the mitochondrial electron-transport chain. The
reducing agent dithiothreitol decreases potassium
current, depolarizes membrane potential, increases
cytosolic calcium, and constricts the pulmonary ar-
tery but has the opposite effects in the ductus arteri-
osus, which it relaxes, thus mimicking the effects
of hypoxia.
 
65
 
 Conversely, oxidizing agents mimic
normoxia in both vessels. In the ductus arteriosus,
where higher levels of oxygen tension (as at birth)
increase reactive oxygen species, exogenous hydro-
gen peroxide mimics oxygen by inhibiting potassi-
um current and depolarizing smooth-muscle cells
of the ductus. Conversely, removal of endogenous
hydrogen peroxide increases potassium current
and hyperpolarizes these cells (Fig. 4).
 
39,66
 
 Thus,
changes in oxygen tension are signaled by changes
in redox status. However, controversy exists, be-
cause some investigators report a decrease in reac-
tive oxygen species during hypoxia, whereas others
report an increase.
 
11,67
 
sources of reactive oxygen species
 
The probable sources of reactive oxygen species are
NADPH and NADH oxidases or mitochondria, or
both (Fig. 4). Genetic models provide evidence for
 
68
 
and against
 
69,70
 
 a role for gp91phox-containing
NADPH oxidase as an oxygen sensor. Potassium
current is increased in neuroepithelial bodies, H146
cells, and adrenomedullary cells by hydrogen per-
oxide, suggesting that an increase in reactive oxy-
gen species, such as hydrogen peroxide, mimics
normoxia
 
59,71
 
; these observations accord with the
view that hypoxia causes a reduction in reactive
oxygen species. Similarly, both hypoxia and an in-
hibitor of NADPH oxidase in pulmonary-artery en-
dothelial cells reduce the release of hydrogen perox-
ide.
 
72
 
 These studies may implicate NADPH oxidase
in oxygen sensing. However, mitochondrial deple-
tion prevents hypoxic contraction of single smooth-
muscle cells in pulmonary arteries,
 
73
 
 and mitochon-
drial inhibitors have opposite effects on potassium
current and tone in the pulmonary artery and in the
ductus arteriosus,
 
39,74-76
 
 suggesting a role for mi-
tochondria in the redox control of vascular tone.
Inhibitors such as rotenone and antimycin (like hy-
poxia itself ) alter the levels of redox signaling mol-
ecules, such as reactive oxygen species and the
electron donors NADH and NADPH.
 
76
 
mitochondria and oxygen sensing 
in the carotid body
Inhibitors of mitochondrial function, such as roten-
one, stimulate the carotid body,77 suggesting that
oxygen sensing is linked to energy metabolism.
Many such inhibitors mimic the effects of hypoxia
on glomus cells by causing inhibition of potassi-
um current.78,79 Moreover, background potassium
channels, such as TASK, are sensitive to intracellu-
lar ATP, which is depleted by hypoxia.79 Although
these observations indicate that the carotid body
is sensitive to changes in energy metabolism, it is
uncertain whether these changes mediate oxygen
sensing.80 A novel hypothesis suggests that potas-
sium current is maintained during normoxia by
carbon monoxide generated by hemoxygenase-2.81
The importance of this interesting concept will be
easier to assess with membrane potential, calcium,
and secretion data.
redox changes and channel gating
Redox changes may alter potassium-channel gating
and calcium release from the sarcoplasmic reticu-
lum. The redox effect may directly affect the con-
ductance of pore-forming a subunits of potassium
channels or could act through associated b sub-
units. For instance, cotransfection of Kvb1.3 with
Kv1.5 into green monkey kidney cells (COS cells)
inactivates Kv1.5 by facilitating NADPH binding to
b subunits; this is reversed by the oxidized pyridine
nucleotide NADP.82 Hypoxia increases the ratio of
reduced to oxidized redox pairs — NADPH–NADP
and NADH–NAD — in the lung,83,84 which would
then inactivate the oxygen-sensitive potassium
channels. A similar redox mechanism controls cal-
cium release from the sarcoplasmic reticulum.85,86
The hypoxic increase in NADH also increases cyclic
ADP ribose, which promotes calcium release from
oxygen signaling
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the sarcoplasmic reticulum of smooth-muscle cells
of the pulmonary arteries87,88 (Fig. 4). Thus, there
is strong evidence linking changes in oxygen ten-
sion to changes in redox status and ultimately to
potassium-channel and sarcoplasmic-reticulum
gating. Although there is a concordance between
low levels of reactive oxygen species and a reduced
cytosolic–redox balance, it remains unclear whether
one predominates as the signal linking the mito-
chondria or oxidase to potassium channels and
sarcoplasmic reticulum.
pulmonary hypertension
The mechanisms of oxygen sensing relate to the
treatment of pulmonary hypertension through iden-
tification of common pathways (control of mem-
brane potential, cell proliferation, and apoptosis)
and of probable therapeutic targets (Kv and store-
operated channels, mitochondrial enzymes, the
electron-transport chain, and Rho kinase). In the
smooth-muscle cells of the pulmonary arteries from
clinical significance
Figure 4. Redox Mechanism for Oxygen Sensing in Specialized Tissues.
Reactive oxygen species (ROS) from the mitochondria, NADPH oxidase, NADH oxidase, or redox couples may control potassium-channel 
gating and membrane potential (Em) and thus calcium entry. The same redox signaling may control calcium release from the sarcoplasmic 
reticulum. The calcium stores in the sarcoplasmic reticulum, in turn, are repleted by calcium entry through the store-operated channels. Rho 
kinase augments the response of actin–myosin at any level of cytosolic calcium (Ca2+i). SOD denotes superoxide dismutase, H2O2 hydrogen 
peroxide, GSH glutathione, and GSSG oxidized glutathione.
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patients with idiopathic pulmonary arterial hyper-
tension, expression of specific potassium channels
(e.g., Kv1.5 and Kv2.1) is reduced, membrane po-
tential is depolarized, and cytosolic calcium is ele-
vated, as compared with cells from patients with
secondary pulmonary hypertension of similar se-
verity.89 This is related in part to abnormal bone
morphogenetic protein-receptor signaling, which
occurs in some patients with idiopathic pulmonary
arterial hypertension.90 The elevation of calcium
promotes smooth-muscle-cell proliferation and hy-
pertrophy in the pulmonary arteries. In addition,
loss of potassium channels increases intracellular
potassium, which inhibits apoptosis by blocking
the activity of proapoptotic caspases.91 Conversely,
enhancing outward potassium current can initiate
apoptosis, and this may be exploited therapeutical-
ly to cause regression of pulmonary hypertension17
(Fig. 5).
The anorectic agent dexfenfluramine has been
shown to increase the incidence of idiopathic pul-
monary arterial hypertension.92 Like hypoxia, ano-
rectic agents inhibit potassium current in smooth-
muscle cells of pulmonary arteries, block both
Kv1.5 and Kv2.1, and release calcium from intra-
cellular stores.93,94 Increased cytoplasmic calcium
is an important signal for smooth-muscle-cell pro-
liferation in the pulmonary arteries17 (Fig. 5). Thus,
there are close parallels between the mechanisms
responsible for hypoxic pulmonary vasoconstric-
tion and those involved in idiopathic pulmonary
arterial hypertension and dexfenfluramine-related
pulmonary hypertension. Conversely, drugs that
enhance potassium current, such as sildenafil,95
dichloroacetate,96 and dehydroepiandrosterone,97
may have a therapeutic benefit in pulmonary hyper-
tension. In experimentally induced pulmonary hy-
pertension, improvement has also been achieved
with the use of aerosolized Kv1.5-channel gene
therapy19 (Fig. 5).
A role for store-operated calcium channels in
idiopathic pulmonary arterial hypertension has
been described recently,98 and dihydropyridines,
such as nifedipine, which block both L-type and
store-operated calcium channels,99 are effective in
approximately 20 percent of these patients.100 More
specific blockers may prove more effective.28 Rho
kinase inhibitors reduce pulmonary hypertension
induced experimentally by monocrotaline or chron-
ic hypoxia.36,101 If the delivery of Rho kinase inhib-
Figure 5. Effects of Decreased Potassium-Channel Function or Expression in Pulmonary-Artery Hypertension.
Decreased function, expression, or both, of potassium channels, initiated by a variety of agents, can lead to vasocon-
striction, proliferation, and decreased apoptosis. Consequently, regression of pulmonary hypertension may be achieved 
by opening potassium channels or increasing potassium-channel expression. Other mechanisms involving the endothe-
lium are not illustrated. K+i denotes cytosolic potassium concentration. Up arrow denotes enhanced expression.
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itors by inhalation prevents the deleterious effects
of systemic vasodilatation,102 they may prove help-
ful in treating pulmonary hypertension.
high-altitude pulmonary edema
Hypoxic pulmonary vasoconstriction is strongest in
small pulmonary arteries but occurs in pulmonary
veins that also express various potassium channels
that control their tone.103 Given the inhibitory ef-
fects of hypoxia on potassium channels, it is not
surprising that patients with high-altitude edema
have increased hypoxic pulmonary vasoconstriction
and higher pulmonary-capillary pressures.104 Drugs
that decrease calcium entry into pulmonary vascu-
lar smooth-muscle cells, such as nifedipine, may
benefit these patients,105 and sildenafil, which in-
creases potassium current in smooth-muscle cells
of the pulmonary arteries, improves exercise capac-
ity at high altitude.106
ductus arteriosus
Persistent patent ductus arteriosus is a common
complication in markedly preterm infants, and
prostaglandin H synthase inhibitors (e.g., indo-
methacin) frequently fail to close the ductus arteri-
osus, necessitating intervention.107 Ex vivo transfer
of the gene for Kv1.5 or Kv2.1 partially restores
constriction to oxygen in the ductus arteriosus of
the preterm rabbit. This may have therapeutic im-
plications in persistent patent ductus arteriosus in
preterm infants.
oxygen sensing in the carotid body
Sensitivity of the carotid body to hypoxia increases
during the early postnatal period, and this corre-
lates with an increase in the magnitude of both
normoxic potassium current and the hypoxic in-
crease in cytosolic calcium. Loss of chemosensitiv-
ity due to carotid-body denervation shortly after the
time of birth produces severe respiratory distur-
bances in several species, resulting in respiratory
instability and unexpected death.108 Similarly, pa-
tients with asthma who are treated with bilateral
carotid-body ablation, a surgical procedure that
is no longer in widespread use, have blunted re-
sponses to hypoxia, and some have died unexpect-
edly.109 Carotid chemoreceptor denervation, which
can occur with surgery of the neck, abolishes eu-
capnic ventilatory responses to hypoxia and reduc-
es ventilatory responses to hypercapnia.110 Sud-
den infant death syndrome could be due in part
to changes in the carotid-body chemoreceptors.111
Dopamine content in the carotid body is higher in
affected children than in normal children,112 and
this higher level could cause carotid-body hypo-
sensitivity, since dopamine is known to inhibit cal-
cium current in glomus cells.113 Interestingly, para-
gangliomas, which are tumors of the carotid body,
can occur spontaneously in those living at high al-
titude, or the tumors can be inherited, because of
mutations causing a loss of function in complex II
of the mitochondria. These findings provide an-
other suggestion that mitochondria are important
in this specialized tissue.114,115
The specialized tissues in the body that sense oxy-
gen share a common mechanism that involves po-
tassium channels, membrane potential, and L-type
calcium channels. In vascular smooth-muscle cells,
oxygen sensing also involves calcium release from
the sarcoplasmic reticulum and calcium entry
through store-operated channels, as well as calcium
sensitization. Changes in cellular redox status may
signal the alterations in oxygen, but whether reac-
tive oxygen species are the key elements remains
to be determined. Improved understanding of the
mechanisms involved in the acute sensing of oxy-
gen helps to explain the pathophysiology of idio-
pathic pulmonary arterial hypertension, persistent
patent ductus arteriosus, and high-altitude pulmo-
nary edema and provides insight into possible
therapy.
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